Company Overview: Nephros

Industry News

17 Mar

Nephros Announces $1.2 Million Private Placement

RIVER EDGE, NJ–(Marketwired – Mar 17, 2017) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of...

Read more

6 Mar

Nephros Receives FDA 510(k) Clearance of EndoPur(TM) Endotoxin 10″ Filter

RIVER EDGE, NJ–(Marketwired – Mar 6, 2017) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration (“HDF”) system for use with a hemodialysis machine for the treatment of...

Read more

14 Feb

Nephros Announces Appointment of Andrew Astor as Chief Financial Officer

RIVER EDGE, NJ–(Marketwired – Feb 14, 2017) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of...

Read more

24 Jan

Nephros Provides Corporate Update and Fourth Quarter 2016 Revenue Guidance

RIVER EDGE, NJ–(Marketwired – Jan 24, 2017) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of...

Read more

27 Dec

Nephros Receives FDA 510(k) Clearance of HydraGuard(TM) 10″ UltraFilter

RIVER EDGE, NJ–(Marketwired – Dec 27, 2016) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration (“HDF”) system for use with a hemodialysis machine for the treatment of...

Read more

11 Oct

Nephros Provides Corporate Update and Third Quarter 2016 Revenue Guidance

RIVER EDGE, NJ / ACCESSWIRE / October 11, 2016 / Nephros, Inc. (NEPH) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with...

Read more

Page 1 of 512345

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address